切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Farnesoid X receptors (FXRs) - 5-HT1 Receptor - ErbB

11件产品中的 1-10

页面
每页
清除全部
  1. Obeticholic Acid
    B4888 Obeticholic Acid
     2 Citation
    中文名: 奥贝胆酸
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥21.5 mg/mL
      insoluble in H2O
  2. SCH 23390 hydrochloride
    B6506 SCH 23390 hydrochloride
    Target: dopamine receptor|5-HT1 Receptor|5-HT2 Receptor
    Summary: 多巴胺受体拮抗剂
      Soluble to 100 mM in sterile water and to 50 mM in ethanol
  3. Methylergometrine maleate
    B6347 Methylergometrine maleate
    中文名: 马来酸甲麦角新碱
    Target: 5-HT1 Receptor|5-HT2 Receptor
    Summary: 5-HT1/5-HT2受体拮抗剂
      Soluble to 25 mM in H2O
  4. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    中文名: 木利替尼
    Target: ErbB
    Summary: HER2/ErbB2有效抑制剂
      ≥76.9 mg/mL
      insoluble in H2O
  5. Naratriptan
    B2251 Naratriptan
    中文名: 盐酸那拉曲坦,盐酸纳拉曲坦
    Target: 5-HT1 Receptor
    Summary: 选择性5-HT1受体亚型激动剂
      ≥61.1 mg/mL
      insoluble in H2O
  6. XL335
    B1528 XL335
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥20.4 mg/mL
      insoluble in H2O
  7. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  8. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    中文名: 沙普替尼
    Target: EGFR|ErbB
    Summary: ErbB抑制剂
      ≥23.7 mg/mL
      insoluble in H2O
  9. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    中文名: 达克替尼
    Target: ErbB
    Summary: HER抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  10. Lapatinib
    A8218 Lapatinib
     2 Citation
    中文名: 拉帕替尼
    Target: ErbB
    Summary: EGFR/HER2抑制剂
      ≥29.05 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页